BGB Group
Buying intent
33 tracked signals | Top 15 topics are below | Marketing is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere BGB Group's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
4d ago
4d ago
4d ago
4d ago
18d ago
5d ago
10d ago
4d ago
12d ago
26d ago
10d ago
4d ago
12d ago
14d ago
11d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at BGB Group
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileBGBx is an independent commercial solutions partner for pharmaceutical and life science companies and their brands, combining consulting, communications, science, creativity, data, technology, innovation, and digital capabilities to deliver breakthrough results. Through BGBx Consulting and BGBx Communications, the company helps clients set strategy early, stay aligned throughout the product lifecy
Top accounts researching BGB Group
names withheld on the public pageThese are companies whose own people brought up BGB Group unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
5,568 companies · 20,395 people are researching Pharmaceutical
BGB Group's own team shows 8 signals on this topic. No one outside BGB Group has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Artificial Intelligence129,094 cos · 649,540 people
- Career Development57,400 cos · 377,367 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Marketing — 1 person; Sales — 1 person
What's been said
public posts by BGB Group's teamNo public post naming BGB Group has surfaced in the past year, so this is what BGB Group's own team is posting about publicly — their topics, in their words.
I can't wait for the ISMPP (International Society for Medical Publication Professionals) Annual Meeting on April 20th —this one feels like a pivotal moment for our field. We're at this incredible inflection point where evolving regulations, increasingly complex data, and the rise of AI are fundamentally reshaping how we communicate science. And honestly? I find that energizing, not intimidating. What excites me most is that AI isn't just speeding things up, it has the potential to make medical communications more precise, more accessible, and more impactful than ever before. Imagine publications that adapt in real time to new evidence, or tools that help authors surface insights buried in mountains of clinical data. We're just scratching the surface. But with that power comes responsibility which is exactly why spaces like ISMPP matter so much. The Society's commitment to integrity, transparency, and collaboration isn't just a mission statement to me; it's the foundation that makes innovation in this space trustworthy and sustainable. It's what I've built my own work around. If you're heading to ISMPP this year, I'd love to connect and swap ideas on where medical communications goes from here. The future of this field is being written right now and we can let shape it together. #ISMPP #MedicalCommunications #LifeSciences #AIinHealthcare #MedComms #Leadership #PrezentAI
Apr 2026